Insider selling
Traded Nov 25, 2025 · filed 3 days laterNot reported under a pre-arranged trading plan
A Quest Diagnostics director sold $240K of Quest Diagnostics shares. The filing does not indicate a pre-arranged trading plan.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Transaction Nov 3, 2025 · Disclosed Dec 11, 2025
Held by the filer's joint per the disclosure. Disclosed 38 days after the transaction; reported as an official range, not an exact amount.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
$1,001–$15,000
Official band as filed. No midpoint or exact amount is implied
Joint
38 days
Days between the transaction date and the filing date
3 disclosures on this company by this filer
No other filers within 90 days
Sponsored 5 bills in Health this Congress.
Bills (H.R. / S.) this member sponsored in the 119th Congress so far, including any introduced after the trade, grouped by the policy area the Congressional Research Service assigned (Congress.gov). Which policy areas relate to which sectors is OQRO's editorial mapping. Not a sign of what they knew or why they traded
Insider selling
Traded Nov 25, 2025 · filed 3 days laterNot reported under a pre-arranged trading plan
A Quest Diagnostics director sold $240K of Quest Diagnostics shares. The filing does not indicate a pre-arranged trading plan.
Insider filing
Traded Nov 25, 2025 · filed 3 days later
Derivative exercise or conversion — not an open-market buy.
J. E. Davis (CEO and President) sold ~$1.79M of Quest Diagnostics
Planned saleEvery dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.